Study guide

11.2 Patient and Caregiver Communication, Education, and Health Literacy

PEBC Pharmacist Evaluating Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & The Canadian Pharmacy Practice Landscape

1.1 PEBC EE Blueprint, Format, Scoring, and IPG Certification Pathway 1.2 The Canadian Healthcare System, Canada Health Act, and Drug Regulation 1.3 Canadian Pharmacy Regulatory Framework, NAPRA Standards, and Professional Legislation

2 Chapter 2: Pharmaceutics & Drug Delivery Systems

2.1 Physicochemical Principles, Solubility, Ionization, and Stability 2.2 Solid Dosage Forms, Formulation Science, and Modified-Release Technologies 2.3 Liquid and Semisolid Dosage Forms, Dispersions, and Topical Delivery 2.4 Sterile Product Principles, Parenteral Delivery, and Biopharmaceuticals 2.5 Pharmaceutical Quality: GMP, Stability Testing, and Bioequivalence

3 Chapter 3: Biopharmaceutics & Clinical Pharmacokinetics

3.1 Drug Absorption, Distribution, Metabolism, and Elimination (ADME) 3.2 Bioavailability, Bioequivalence, and Biopharmaceutics Classification System (BCS) 3.3 Pharmacokinetic Modeling, Parameters, and Dosing Calculations 3.4 Therapeutic Drug Monitoring (TDM) and Clinical Application

4 Chapter 4: Pharmacology, Toxicology & Pharmacogenetics

4.1 Autonomic and Central Nervous System Pharmacology 4.2 Cardiovascular, Renal, and Endocrine Pharmacology 4.3 Clinical Toxicology, Overdose Management, and Antidotes 4.4 Biologics, Biosimilars, and Pharmacogenetics

5 Chapter 5: Pathophysiology & Clinical Assessment

5.1 Clinical Laboratory Diagnostics, Biomarkers, and Vital Signs 5.2 Cardiovascular and Respiratory Pathophysiology 5.3 Endocrine, Renal, and Gastrointestinal Pathophysiology 5.4 Neurologic, Psychiatric, and Musculoskeletal Pathophysiology 5.5 Physical Assessment and Point-of-Care Testing

6 Chapter 6: Pharmacotherapy & Minor Ailments

6.1 Cardiovascular Pharmacotherapy & Evidence-Based Guidelines 6.2 Endocrine and Metabolic Pharmacotherapy 6.3 Infectious Diseases and Antimicrobial Stewardship 6.4 Neurologic, Psychiatric, and Pain Management Therapeutics 6.5 Minor Ailment Prescribing and Nonprescription Therapy 6.6 Respiratory Pharmacotherapy: Asthma, COPD, and Inhaled Therapy 6.7 Gastrointestinal and Hepatic Pharmacotherapy 6.8 Renal, Fluid, and Electrolyte Therapeutics 6.9 Musculoskeletal and Rheumatologic Pharmacotherapy 6.10 Dermatologic, Ophthalmic, and Ear-Nose-Throat Pharmacotherapy 6.11 Hematologic, Immunologic, and Oncology Supportive Care 6.12 Women's Health, Men's Health, and Urologic Therapeutics 6.13 Nutrition, Natural Health Products, and Complementary Medicine

7 Chapter 7: Special Populations & Applied Therapeutics

7.1 Geriatric Pharmacotherapy and Deprescribing 7.2 Pediatric and Neonatal Pharmacotherapy 7.3 Perinatal Pharmacotherapy: Pregnancy and Lactation 7.4 Dosage Adjustments in Renal and Hepatic Impairment

8 Chapter 8: Prescription Processing, Calculations & Compounding

8.1 Prescription Processing, Verification, and Drug Therapy Problem Management 8.2 Pharmaceutical Calculations and Clinical Math 8.3 Non-Sterile Compounding and NAPRA Standards 8.4 Sterile and Hazardous Compounding under NAPRA Standards 8.5 Advanced Calculations: Infusion Rates, Parenteral Nutrition, and Renal Estimation

9 Chapter 9: Health Equity, Indigenous Health & Pharmacy Bioethics

9.1 Social Determinants of Health and Health Equity 9.2 Indigenous Health, Cultural Safety, and Humility 9.3 Pharmacy Bioethics, Informed Consent, and Professional Boundaries 9.4 Health Promotion, Disease Prevention, and Public Health

10 Chapter 10: Evidence Appraisal, Safety & Practice Management

10.1 Biostatistics and Critical Appraisal of Clinical Literature 10.2 Pharmacoeconomics and Pharmacoepidemiology 10.3 Medication Safety, Incident Analysis, and Quality Improvement 10.4 Pharmacy Operations, Cold-Chain Management, and Emergency Preparedness 10.5 Drug Information and Evidence-Based Decision Making 10.6 Pharmacovigilance and Adverse Drug Reaction Reporting in Canada

11 Chapter 11: Patient Care Process, Communication & Collaborative Practice

11.1 The Patient Care Process: Assessment, Care Plans, and Follow-Up 11.2 Patient and Caregiver Communication, Education, and Health Literacy 11.3 Motivational Interviewing and Shared Decision-Making 11.4 Intra- and Interprofessional Collaborative Care

12 Chapter 12: Medication Administration, Devices & Expanded Scope

12.1 Injection and Vaccine Administration Technique 12.2 Immunization Schedules, Vaccine Selection, and Travel Health 12.3 Home Medical Devices and Device Technique Coaching 12.4 Expanded Scope: Adapting, Renewing, Initiating, and Medication Reconciliation

13 Chapter 13: Pharmacy Management, Finance & Practice Leadership

13.1 Human Resources, Leadership, and Change Management 13.2 Financial Management, Drug Plans, and Marketing 13.3 Quality Improvement, Risk Management, and Workplace Safety

11.2 Patient and Caregiver Communication, Education, and Health Literacy

Key Takeaways Explain This Topic AI

Open-ended questions gather clinical information; closed questions confirm details, so a consultation opens broadly and narrows.

Teach-back asks the patient to explain the plan in their own words and is the only reliable check that education has been understood.

Roughly 60% of Canadian adults have below-adequate health literacy, so plain language and demonstration are the default, not an accommodation.

A trained professional interpreter should be used instead of a family member, particularly a child, whenever a language barrier affects clinical accuracy or confidentiality.

Risk is understood far better as natural frequencies — 2 people in 100 — than as relative risk reductions or percentages.

Last updated: August 2026

11.2 Patient and Caregiver Communication, Education, and Health Literacy

Exam Focus: Communication (patient and caregiver education) is a named subcategory of Pharmacy Practice on the PEBC blueprint. Items test technique, not personality: which question opens the consultation, how understanding is verified, and how risk is framed so the patient can act on it.

Structuring the Consultation

A medication consultation moves from broad to specific.

Open and orient. Introduce yourself and your role, confirm identity, ask permission, and state how long it will take and what will be covered.

Gather with open-ended questions. "What did the doctor tell you this medication is for?" and "How have you been taking it?" surface more than yes-or-no questions.

Narrow with closed questions to confirm specifics: dose, timing, missed doses, allergy details.

Provide information in small chunks, checking after each.

Verify with teach-back and agree next steps.

Close by inviting questions and stating how to reach you.

The classic three prime questions for a new prescription remain a reliable structure: what did the prescriber tell you the medication is for, how did they tell you to take it, and what did they tell you to expect?

For a refill, the three questions shift to: what are you taking it for, how are you actually taking it, and what problems are you having?

Verbal and Non-Verbal Technique

Non-verbal behaviour carries much of the message. Sit or stand at eye level rather than across a raised counter, maintain culturally appropriate eye contact, keep an open posture, and control the environment for privacy. A consultation conducted with the pharmacist half-turned to a screen is read accurately by the patient as low priority.

Active listening means allowing silence, avoiding interruption, and reflecting content back — "so the tablets are helping the pain but the drowsiness is stopping you driving." Reflection confirms accuracy and demonstrates attention simultaneously.

Empathy is the accurate recognition of the patient's emotional state and its explicit acknowledgement. It is distinct from sympathy, which centres the pharmacist's own feelings. "That sounds exhausting, especially with the night shifts" is empathic. "I'm so sorry, that's awful" is sympathetic and offers less. Empathy improves disclosure, adherence, and satisfaction, and it costs one sentence.

Language to avoid: jargon ("hepatotoxicity", "titrate", "prophylaxis"), judgemental framing ("you're non-compliant"), and false reassurance ("don't worry, it's nothing"). Replace them with plain terms, neutral framing, and honest uncertainty.

Health Literacy

Health literacy is the ability to obtain, process, and understand health information well enough to make decisions. Approximately 60% of Canadian adults, and a higher proportion of adults over 65, score below the level considered adequate. Low health literacy is invisible: patients compensate skilfully, nod, and say they understand.

Apply universal precautions — communicate so that everyone can understand, rather than trying to identify who cannot.

  • Instead of Use
  • "Take one tablet BID" "Take one tablet in the morning and one in the evening"
  • "Take as directed" "Take one tablet with breakfast"
  • "This is for hypertension" "This is for your high blood pressure"
  • "Adverse effects include nephrotoxicity" "This medicine can affect your kidneys, so we check a blood test"
  • "Take on an empty stomach" "Take it one hour before food or two hours after"

Reinforce speech with demonstration (inhalers, injections, blood glucose meters, eye drops), written material at a grade 6 to 8 reading level , pictograms , and written schedules . Limit each consultation to three or four key points; more is not retained.

Teach-Back

Teach-back is the verification step. Ask the patient to explain the plan back in their own words, framing it as a check on your explanation rather than a test of the patient:

"I want to make sure I explained this clearly. Can you tell me how you're going to take the new inhaler when you get home?"

If the explanation is incomplete, re-explain differently — not louder or in the same words — and check again. For a device, use show-back : the patient demonstrates the technique. Written information alone, with no verification, is not education.

Interpreters and Cultural Considerations

When language limits accuracy, use a trained professional interpreter , in person or by telephone. Avoid using family members, and never a child, because it compromises confidentiality, invites filtering of sensitive content, and imposes an inappropriate role. Speak to the patient rather than to the interpreter, use short segments, and allow additional time.

Culturally respectful communication also means asking about beliefs regarding illness and medicines, fasting practices that affect dosing schedules, and preferences about who participates in decisions — without assuming those preferences from ethnicity or name.

Communicating Risk and Benefit

Patients consistently misinterpret relative risk. Use natural frequencies with a consistent denominator :

Poor: "This drug reduces your risk of stroke by 30%."

Better: "Out of 100 people like you, about 4 would have a stroke over 5 years without this medicine, and about 3 would with it. So it prevents a stroke for roughly 1 in 100 people."

Present benefit and harm on the same scale and over the same time period, and use a visual aid such as a 100-person diagram where possible. Acknowledge uncertainty honestly rather than overstating precision.

Medication Reviews and Nonprescription Consultations

A comprehensive medication review examines every product a patient takes for indication, effectiveness, safety, and adherence, produces a documented plan, and is shared with the patient and the prescriber. Bring all products to the appointment, allow enough time, and prioritise the two or three highest-value changes rather than presenting a list of twelve.

A nonprescription consultation is a clinical assessment, not a sale. Gather the essentials before recommending anything: who the product is for, what the symptoms are and how long they have lasted, what has been tried, what other conditions and medications exist, allergies, and whether the person is pregnant or breastfeeding. Screen explicitly for red flags requiring referral, and document significant recommendations.